Overview

A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesimâ„¢

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The Study was designed to evaluate the pharmacokinetics of DHA and PQ in healthy volunteers and to assess the effect of ethnicity (Asian vs Caucasian), gender and body weight on the relative bioavailability of DHA and PQ.
Phase:
Phase 1
Details
Lead Sponsor:
sigma-tau i.f.r. S.p.A.
Collaborator:
CPR Pharma Services Pty Ltd, Australia
Treatments:
Dihydroartemisinin
Piperaquine